Teladoc Health (TDOC) Raw Materials (2020 - 2023)

Teladoc Health (TDOC) has 4 years of Raw Materials data on file, last reported at $26.4 million in Q1 2023.

• For the quarter ending Q1 2023, Raw Materials rose 5.59% year-over-year to $26.4 million; the trailing twelve-month figure through Mar 2023 stood at $26.4 million (up 5.59% YoY), and the FY2022 full-year result was $30.1 million, up 5.56% from the prior year.
• Raw Materials slipped to $26.4 million in Q1 2023, from $30.1 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $30.1 million in Q4 2022 to a low of $17.0 million in Q2 2022.
• A 4-year average of $23.8 million and a median of $23.9 million in 2021 frame the typical range for Raw Materials.
• Across the five-year window, Raw Materials soared 45.68% in 2021 and fell 25.39% in 2022, its largest moves.
• Tracing TDOC's Raw Materials over 4 years: stood at $19.6 million in 2020, then surged by 45.68% to $28.5 million in 2021, then gained by 5.56% to $30.1 million in 2022, then retreated by 12.36% to $26.4 million in 2023.
• Business Quant data shows TDOC's Raw Materials at $26.4 million in Q1 2023, $30.1 million in Q4 2022, and $27.6 million in Q3 2022.